Metabolic benefits of DAs have been demonstrated to occur even in absence of PRL excess
GLP-1RA therapy, when prolonged and potent, may lead to a form of iatrogenic ERM : Short-term gains: lower glucose, lower weight, lower cardiovascular risk Long-term risks: impaired amino-acid balance, reduced re-anabolism, muscle loss, frailty, diminished resilience This progression can be subtle and clinically silentbiochemically detectable long before symptoms appear
Frequency drops
For 175 years, we have worked to make a difference for all who rely on us
At Set Point Medical Weight Loss Clinic, our team provides individualized guidance on nutrition, exercise, and behavioral strategies to complement tirzepatide therapy
For instance, while Trulicity for weight management is meant for a single-use only, Ozempic pen can be used multiple times